1. Home
  2. CDT vs CARV Comparison

CDT vs CARV Comparison

Compare CDT & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • CARV
  • Stock Information
  • Founded
  • CDT 2019
  • CARV 1948
  • Country
  • CDT United States
  • CARV United States
  • Employees
  • CDT 7
  • CARV N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • CARV Savings Institutions
  • Sector
  • CDT Health Care
  • CARV Finance
  • Exchange
  • CDT Nasdaq
  • CARV Nasdaq
  • Market Cap
  • CDT 9.0M
  • CARV 9.0M
  • IPO Year
  • CDT N/A
  • CARV 1994
  • Fundamental
  • Price
  • CDT $0.07
  • CARV $1.86
  • Analyst Decision
  • CDT
  • CARV
  • Analyst Count
  • CDT 0
  • CARV 0
  • Target Price
  • CDT N/A
  • CARV N/A
  • AVG Volume (30 Days)
  • CDT 16.2M
  • CARV 21.7K
  • Earning Date
  • CDT 02-14-2025
  • CARV 02-12-2025
  • Dividend Yield
  • CDT N/A
  • CARV N/A
  • EPS Growth
  • CDT N/A
  • CARV N/A
  • EPS
  • CDT N/A
  • CARV N/A
  • Revenue
  • CDT N/A
  • CARV $28,323,000.00
  • Revenue This Year
  • CDT N/A
  • CARV N/A
  • Revenue Next Year
  • CDT N/A
  • CARV N/A
  • P/E Ratio
  • CDT N/A
  • CARV N/A
  • Revenue Growth
  • CDT N/A
  • CARV 9.41
  • 52 Week Low
  • CDT $0.06
  • CARV $1.26
  • 52 Week High
  • CDT $5.44
  • CARV $2.39
  • Technical
  • Relative Strength Index (RSI)
  • CDT 40.15
  • CARV 58.89
  • Support Level
  • CDT $0.08
  • CARV $1.78
  • Resistance Level
  • CDT $0.09
  • CARV $1.90
  • Average True Range (ATR)
  • CDT 0.01
  • CARV 0.09
  • MACD
  • CDT -0.00
  • CARV 0.00
  • Stochastic Oscillator
  • CDT 27.18
  • CARV 75.00

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About CARV Carver Bancorp Inc.

Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.

Share on Social Networks: